Bioxytran, Inc. (BIXT)
USD 0.09
(-0.89%)
USD 0.09
(-0.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -775.37 Thousand | -1.8 Million | -1.69 Million | -1.09 Million | -431.03 Thousand | -185.9 Thousand |
| Net Income | -4.28 Million | -2.65 Million | -4.52 Million | -2.54 Million | -1.85 Million | -296.41 Thousand |
| Depreciation & Amortization | 8285.00 | 3644.00 | 77.03 Thousand | 259.05 Million | - | 5173.00 |
| Deferred income taxes | - | - | -77.03 Thousand | -259.05 Million | - | - |
| Stock-based compensation | 197.55 Thousand | 178.38 Thousand | 582.86 Thousand | 247.86 Thousand | 1.12 Million | - |
| Change in working capital | 2.98 Million | 303.8 Thousand | 2.17 Million | 262.65 Thousand | 120.58 Thousand | 32.92 Thousand |
| Other non-cash items | -1.74 Million | 365.8 Thousand | 77.03 Thousand | 933.01 Thousand | 185.16 Thousand | 72.41 Thousand |
| Investing Cash Flow | -44.3 Thousand | -32.24 Thousand | -36.93 Thousand | -10 Thousand | - | - |
| Investments in PPE | -44.3 Thousand | -32.24 Thousand | -36.93 Thousand | -10 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -44.3 Thousand | -32.24 Thousand | -36.93 Thousand | -10 Thousand | - | - |
| Financing Cash Flow | 550.36 Thousand | 2.06 Million | 1.76 Million | 981.05 Thousand | 564.25 Thousand | 222.2 Thousand |
| Debt repayment | - | -1.38 Million | -1.16 Million | -232.94 Thousand | -250 Thousand | -222.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 550.36 Thousand | 680 Thousand | 600 Thousand | 950 Thousand | 20 Thousand | - |
| Other Financing Activities | 550.36 Thousand | 2.76 Million | 1.76 Million | 264 Thousand | 794.25 Thousand | 222.2 Thousand |
| Accounts receivables | - | - | - | 50 Thousand | -50 Thousand | - |
| Accounts payables | 2.26 Million | 303.8 Thousand | 1.89 Million | 487.37 Thousand | 170.58 Thousand | 32.92 Thousand |
| Inventory | - | - | - | -50 Thousand | 50 Thousand | - |
| Other working capital | 720.87 Thousand | 125.07 Thousand | 274.71 Thousand | -224.71 Thousand | -50 Thousand | 32.92 Thousand |
| Cash at beginning of period | 295.4 Thousand | 72.35 Thousand | 41.68 Thousand | 169.62 Thousand | 36.41 Thousand | 110.00 |
| Cash at end of period | 26.08 Thousand | 295.4 Thousand | 72.35 Thousand | 41.68 Thousand | 169.62 Thousand | 36.41 Thousand |
| Capital Expenditure | -44.3 Thousand | -32.24 Thousand | -36.93 Thousand | -10 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -269.31 Thousand | 223.04 Thousand | 30.67 Thousand | -127.94 Thousand | 133.21 Thousand | 36.3 Thousand |
| Free Cash Flow | -819.67 Thousand | -1.83 Million | -1.73 Million | -1.1 Million | -431.03 Thousand | -185.9 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -392.37 Thousand | -661.71 Thousand | -800.32 Thousand | -1.04 Million | -4.28 Million | -1.07 Million |
| Depreciation & Amortization | 1516.00 | 1536.00 | 2031.00 | 3780.00 | 8285.00 | 1803.00 |
| Deferred income taxes | - | - | - | -18.26 Thousand | - | - |
| Stock-based compensation | 38.87 Thousand | 65.69 Thousand | 300.24 Thousand | 40.28 Thousand | 197.55 Thousand | 138.55 Thousand |
| Change in working capital | 358.95 Thousand | 509.23 Thousand | 272.24 Thousand | 931.64 Thousand | 2.98 Million | 544.74 Thousand |
| Other non-cash items | 25 Thousand | 99.55 Thousand | 454.54 Thousand | 24.02 Thousand | -1.74 Million | 44.28 Thousand |
| Investing Cash Flow | -10.82 Thousand | -1051.00 | -5995.00 | -6561.00 | -44.3 Thousand | -12.69 Thousand |
| Investments in PPE | -10.82 Thousand | -1051.00 | -5995.00 | -6561.00 | -44.3 Thousand | -12.69 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.82 Thousand | -1051.00 | -5995.00 | -6561.00 | -44.3 Thousand | -12.69 Thousand |
| Financing Cash Flow | - | 59 Thousand | 65.5 Thousand | 45 Thousand | 550.36 Thousand | 390.36 Thousand |
| Debt repayment | -61.5 Thousand | - | -61.5 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -63 Thousand | 59 Thousand | 4000.00 | 45 Thousand | 550.36 Thousand | 390.36 Thousand |
| Other Financing Activities | 61.5 Thousand | 59 Thousand | 4000.00 | 45 Thousand | 550.36 Thousand | 390.36 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 358.95 Thousand | - | - | 1999.00 | 2.26 Million | 544.74 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -781.48 Thousand | 509.23 Thousand | 272.24 Thousand | 929.64 Thousand | 720.87 Thousand | -1.72 Million |
| Cash at beginning of period | 13.52 Thousand | 10.02 Thousand | 26.08 Thousand | 80.27 Thousand | 295.4 Thousand | 45.18 Thousand |
| Cash at end of period | 34.67 Thousand | 13.52 Thousand | 10.02 Thousand | 26.08 Thousand | 26.08 Thousand | 80.27 Thousand |
| Capital Expenditure | -10.82 Thousand | -1051.00 | -5995.00 | -6561.00 | -44.3 Thousand | -12.69 Thousand |
| Effect of forex changes on cash | - | - | - | -17.84 Thousand | - | 17.84 Thousand |
| Net cash flow / Change in cash | 21.15 Thousand | 3498.00 | -16.06 Thousand | -54.18 Thousand | -269.31 Thousand | 35.09 Thousand |
| Free Cash Flow | 21.15 Thousand | -55.5 Thousand | -81.56 Thousand | -99.18 Thousand | -819.67 Thousand | -355.26 Thousand |
HCGI
AIT
BRL
SBNEXT
ZTSTF
688071